Objective: To observe the effects of Lüfukang Capsules ( LFKC) on arrhythmia induced by ligation of coronary artery in dogs. Methods: Thirty dogs were randomly divided into 5 groups, the model group administrated with equal volume of distilled water, the positive control group administrated with Wenxin Granules ( ), and the small, medium and large dosage LFKC groups, 6 dogs in each group. Thirty minutes after medication, electrocardiogram was conducted and the time of arrhythmia occurrence, times of ventricular premature beat (VP), and incidence rates of ventricular tachycardia (VT) and ventricular fibrillation (VF) were recorded in the model dogs with arrhythmia induced by ligation of coronary artery. Results: Compared with the model group, the occurrence time of arrhythmia induced by the coronary artery ligation in the medium and large LFKC groups was significantly delayed (20.45±9.10 and 19.92±3.78, respectively, both P<0.05). The frequency of VP in the medium and large LFKC groups was also significantly decreased (8.17±6.62 and 3.83±2.79, respectively, both P<0.01). Conclusion: LFKC has anti-arrhythmic effects for the experimental arrhythmia induced by the ligation of coronary artery in dogs.
Arrhythmia refers to the abnormities in the frequency, rhythm and original site of cardiac impulse, which is one of the symptoms commonly seen in cardiovascular diseases. Arrhythmia not only occurs in the patients with cardiovascular diseases, but also in the patients of non-cardiovascular diseases or healthy persons. The clinical manifestations may include anxiety, palpitation, shortness of breath, weakness, chest pain, sweating, irritability, dizziness, unsound sleep, and pale or dark red tongue with petechiae and ecchymosis, and with yellow, greasy, thin white or less fur, and the pulse, knotted, intermittent, rapid, and uneven. 1 Arrhythmias may sometimes induce abnormal awareness of heart beat, making people feel only restlessness, and sometimes cause life-threatening emergencies, such as cardiac arrest or even sudden death. Rapid ventricular arrhythmia induced cardiac death is the most common cause of death in the United States, 250,000-500,000 cases die each year, accounting for 10%-20% of the adult death rate. 2 At present, there are many antiarrhythmics with different mechanisms. However, their clinical use is often limited by the frequent side effects, especially for the induced arrhythmic effects. 3, 4 Lüfukang Capsules ( LFKC) has long been used for clinical treatment of arrhythmia with satisfactory therapeutic results, indicating that it is an effective antiarrhythmic. [5] [6] [7] [8] In the present study, the effects of LFKC for arrhythmia induced by ligation of the coronary artery were investigated in dogs. 
METHODS

Medicines
Animal Modeling and Grouping
The experiment complied with the Animal Management Rule of the Ministry of Health, PRC, and the experimental protocol was approved by the Animal Care Committee of Guangdong College of Pharmacy. Thirty Beagle dogs were housed at the Animal Care Center of Guangdong College of Pharmacy.
The arrhythmia model was prepared with a modified method according to previous description. 9 Five days after adaptive feeding, each animal was anesthetized with 0.8% pentobarbital sodium via intraperitoneal injection, followed by endotracheal intubation, and mechanical ventilation. After thoracotomy, the heart was exposed and the left anterior descending branch of coronary artery was ligated with a complete and permanent occlusion, resulting in acute myocardial infarction. Additionally, an arterial catheter with heparin was inserted from the femoral artery to the abdominal aorta for continuous measurement of the arterial blood pressure. After the chest wall was sutured and artificial respiration was stopped, the dogs were transferred to specialized cages. The dogs were randomly divided (using random number table) into five groups: the model group, the positive control group, and the small, medium and large dose LFKC groups, 6 dogs (3 male and 3 female) in each group.
Medicine Dosages and Administration Methods
For the small dose LFKC group, 0.53 g crude drug/kg was intragastrically administrated, once per day. The dosage corresponded to 1 time of the clinical human dose according to the body surface area, or 1.6 times of clinical 60-kilogram adult dosage according to the body weight. Just before use, the contents of the LFKC Capsules were prepared into 1.91% solution with distilled water, which contained 10.60% crude drug, and 5 mL/kg was given each time.
For the medium dose LFKC group, 1.060 g crude drug/kg was intragastrically administrated, once per day. The dosage corresponded to 2 times of the clinical human dose according to the body surface area, or 3.2 times of clinical 60-kilogram adult dosage according to the body weight. Just before use, the contents of the LFKC Capsules were prepared into 3.82% solution with distilled water, which contained 21.20% crude drug and 5 mL/kg was given each time.
For the large dose LFKC group, 2.120 g crude drug/kg was intragastrically administrated, once per day. The dosage corresponded to 4 times of clinical human dose according to the body surface area, or 6.4 times of clinical 60-kilogram adult dosage according to the body weight. Just before use, the contents of the LFKC Capsules were prepared into 7.64% solution with distilled water, which contained 42.40% crude drug and 5 mL/kg was given each time.
For the positive control group, 1.440 g crude drug/kg was intragastrically administrated, once per day. The dosage corresponded to 2 times of the clinical human dose according to the body surface area, or 3.2 times of clinical 60-kilogram adult dosage according to the body weight. Just before use, Wenxin Granules were prepared into 28.80% solution with distilled water, and 5 mL/kg was given each time.
For the model group, 5 ml/kg distilled water was intragastrically administrated, once each day.
Thirty min after intragastric administration, the left anterior descending branch of coronary artery was ligated.
Indexes of Observation
After the end of modeling, ECG was immediately conducted, and the time of arrhythmia occurrence, times of ventricular premature beats (VP) in one min, and incidence rates of ventricular tachycardia (VT) and ventricular fibrillation (VF) were recorded and calculated.
Statistical Analysis
The data were processed with software of SPSS, v12.0 (SPSS Inc., Chicago, IL, USA) for windows, and expressed as x s. Differences between two groups were assessed by unpaired Student's t-test, and one-way ANOVA was used for comparison among multiple groups. P<0.05 was regarded as statistically significant difference. Table 1 , LFKC significantly delayed the time of arrhythmia occurrence in coronary artery-ligated dogs, and reduced the times of VP and the incidence rates of VT and VF, with significant differences as compared with the model group (P <0.01 or 0.05). 
RESULTS
As shown in the
SUMMARY
According to the TCM theories, qi and blood are the fundamental substances for nourishing the heart. People with congenital deficiency, or infirm with age and prolonged diseases,are susceptible to arrhythmias because of the damage of qi and blood. LFKC is the authors' experiential prescription for treating arrhythmia, which is composed of Hongshen (Radix Ginseng Rubra), Maidong (Radix Ophiopogonis), Shashen (Radix Adenophorae), Longyanrou (Dried Longan Pulp), Suanzaoren (Spine Date Seed), Danshen (Radix Salviae Miltiorrhizae), Wuweizi (Fructus Schisandrae) and Longchi (Fossilia Dentis Mastodi), etc. In the recipe, Hongshen (Radix Ginseng Rubra) and Longyanrou Dried Longan Pulp) functions to enrich the heart blood; Shashen (Radix Adenophorae) and Maidong (Radix Ophiopogonis) can reinforce the heart-yin; Suanzaoren (Spine Date Seed) has the effect of invigorating the heart-qi; Sheng Longchi (Fossilia Dentis Mastodi) may tranquilize the mind; Danshen (Radix Salviae Miltiorrhizae) can promote and regulate the flow of qi and blood. So, the whole recipe has functions of supplementing qi and nourishing yin, nourishing the blood to tranquilize the mind, resuming regular heart rate and relieving palpitation.
The results from the present study show that LFKC can significantly delay the time of arrhythmia occurrence, reduce the frequency of VP and decrease the occurrence rates of VT and VF in the dog with coronary artery ligation, exerting better antiarrythmic effects as compared with Wenxin Granules, which can be used for preventing cardiac sudden death and other major cardiac events. 10 
